Junwen Qu

476 total citations
18 papers, 309 citations indexed

About

Junwen Qu is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Junwen Qu has authored 18 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Immunology. Recurrent topics in Junwen Qu's work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Gallbladder and Bile Duct Disorders (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Junwen Qu is often cited by papers focused on Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Gallbladder and Bile Duct Disorders (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Junwen Qu collaborates with scholars based in China and United States. Junwen Qu's co-authors include Kewei Li, Zhiqing Yuan, Guiyang Wang, Xiaopeng Wang, Xiaopeng Wang, Ming Zhang, Lai Guan Ng, Guiyang Wang, Haoyu Wu and Xiaopeng Wang and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Junwen Qu

17 papers receiving 303 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junwen Qu China 11 130 82 76 74 55 18 309
Zhiqing Yuan China 11 118 0.9× 102 1.2× 67 0.9× 27 0.4× 69 1.3× 16 280
Jörg‐Martin Bangen Germany 5 205 1.6× 39 0.5× 111 1.5× 40 0.5× 53 1.0× 6 365
Masayuki Endo Japan 9 109 0.8× 53 0.6× 44 0.6× 47 0.6× 31 0.6× 20 323
Beatriz Lozano‐Ruiz Spain 10 164 1.3× 45 0.5× 71 0.9× 150 2.0× 34 0.6× 11 340
Jeroen Roelofsen Netherlands 12 168 1.3× 43 0.5× 74 1.0× 24 0.3× 28 0.5× 18 329
Can Gan China 10 167 1.3× 72 0.9× 168 2.2× 86 1.2× 36 0.7× 17 423
Xiaochun Zhu China 13 81 0.6× 62 0.8× 54 0.7× 61 0.8× 57 1.0× 23 369
Min Deng China 12 103 0.8× 64 0.8× 51 0.7× 29 0.4× 75 1.4× 28 337
Yuichiro Yamamoto Japan 10 135 1.0× 21 0.3× 58 0.8× 46 0.6× 39 0.7× 29 356
Veronika Skuginna Switzerland 6 138 1.1× 117 1.4× 21 0.3× 138 1.9× 77 1.4× 9 369

Countries citing papers authored by Junwen Qu

Since Specialization
Citations

This map shows the geographic impact of Junwen Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwen Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwen Qu more than expected).

Fields of papers citing papers by Junwen Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junwen Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwen Qu. The network helps show where Junwen Qu may publish in the future.

Co-authorship network of co-authors of Junwen Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Junwen Qu. A scholar is included among the top collaborators of Junwen Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junwen Qu. Junwen Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sun, Nan, Junwen Qu, Cheng Qian, et al.. (2025). High glucose/ChREBP-induced Hif-1α transcriptional activation in CD4+ T cells reduces the risk of diabetic kidney disease by inhibiting the Th1 response. Diabetologia. 68(5). 1044–1056. 4 indexed citations
2.
Li, Fangzhou, Liya Wang, Zhongping Lai, et al.. (2025). Neutrophil extracellular trap-derived double-stranded RNA aggravates PANoptosis in renal ischemia reperfusion injury. Cell Communication and Signaling. 23(1). 140–140. 8 indexed citations
3.
Wang, Dongxu, et al.. (2025). Deciphering metabolic reprogramming of immune cells within the tumor microenvironment. Journal of Translational Medicine. 23(1). 1055–1055.
4.
Sun, Nan, et al.. (2024). Molecular characterization of m6A RNA methylation regulators with features of immune dysregulation in IgA nephropathy. Clinical and Experimental Medicine. 24(1). 92–92. 1 indexed citations
5.
Miao, Naijun, Dongqing Cao, Jingsi Jin, et al.. (2024). Tumor cell–intrinsic Piezo2 drives radioresistance by impairing CD8+ T cell stemness maintenance. The Journal of Experimental Medicine. 221(10). 5 indexed citations
6.
Qu, Junwen, Dawei Li, Nan Sun, et al.. (2023). Hypoxia-Inducible Factor 2α Attenuates Renal Ischemia-Reperfusion Injury by Suppressing CD36-Mediated Lipid Accumulation in Dendritic Cells in a Mouse Model. Journal of the American Society of Nephrology. 34(1). 73–87. 19 indexed citations
7.
Qu, Junwen, et al.. (2023). Neutrophil diversity and plasticity: Implications for organ transplantation. Cellular and Molecular Immunology. 20(9). 993–1001. 28 indexed citations
8.
Li, Dawei, Hui Xie, Xiaowen Liu, et al.. (2023). Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury. Frontiers in Immunology. 14. 1117297–1117297. 10 indexed citations
9.
Qu, Junwen, et al.. (2022). Mesenchymal Stem Cells Alleviate Renal Fibrosis and Inhibit Autophagy via Exosome Transfer of miRNA-122a. Stem Cells International. 2022. 1–14. 19 indexed citations
10.
Li, Dawei, Haoyu Wu, Junwen Qu, et al.. (2022). Prophylactic effect of low-dose trimethoprim-sulfamethoxazole for Pneumocystis jirovecii pneumonia in adult recipients of kidney transplantation: a real-world data study. International Journal of Infectious Diseases. 125. 209–215. 10 indexed citations
11.
Yuan, Zhiqing, Yingbin Liu, Xuxu Sun, et al.. (2021). A redox probe screens MTHFD1 as a determinant of gemcitabine chemoresistance in cholangiocarcinoma. Cell Death Discovery. 7(1). 89–89. 5 indexed citations
12.
Huang, Pei-Qi, Junwen Qu, Ruoyang Chen, et al.. (2021). Targeting P2RX1 alleviates renal ischemia/reperfusion injury by preserving mitochondrial dynamics. Pharmacological Research. 170. 105712–105712. 29 indexed citations
13.
Wang, Xiaopeng, et al.. (2020). Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis. Frontiers in Pharmacology. 11. 200–200. 38 indexed citations
14.
Wang, Xiaopeng, Junwen Qu, & Kewei Li. (2020). Duodenal perforations secondary to a migrated biliary plastic stent successfully treated by endoscope: case-report and review of the literature. BMC Gastroenterology. 20(1). 149–149. 15 indexed citations
15.
Qu, Junwen, et al.. (2019). Feasibility and safety of single-incision laparoscopic cholecystectomy versus conventional laparoscopic cholecystectomy in an ambulatory setting. Hepatobiliary & pancreatic diseases international. 18(3). 273–277. 16 indexed citations
16.
Qu, Junwen, Zhiqing Yuan, Guiyang Wang, Xiaopeng Wang, & Kewei Li. (2019). The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice. International Immunopharmacology. 70. 147–155. 80 indexed citations
17.
Yuan, Zhiqing, Guiyang Wang, Junwen Qu, Xiaopeng Wang, & Kewei Li. (2018). 9-cis-retinoic acid elevates MRP3 expression by inhibiting sumoylation of RXRα to alleviate cholestatic liver injury. Biochemical and Biophysical Research Communications. 503(1). 188–194. 10 indexed citations
18.
Qu, Junwen, Guiyang Wang, Zhiqing Yuan, & Kewei Li. (2017). Hem-o-lok Clips Migration: An Easily Neglected Complication after Laparoscopic Biliary Surgery. SHILAP Revista de lepidopterología. 2017. 1–4. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026